News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,285 Results
Type
Article (42148)
Company Profile (274)
Press Release (684848)
Multimedia
Podcasts (86)
Webinars (18)
Section
Business (205812)
Career Advice (2050)
Deals (35701)
Drug Delivery (113)
Drug Development (81913)
Employer Resources (173)
FDA (16523)
Job Trends (15072)
News (348468)
Policy (33103)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2608)
Accelerated approval (31)
Adcomms (25)
Allergies (143)
Alliances (49991)
ALS (169)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (312)
Approvals (16785)
Artificial intelligence (518)
Autoimmune disease (152)
Automation (38)
Bankruptcy (370)
Best Places to Work (11728)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (179)
Bladder cancer (158)
Brain cancer (56)
Breast cancer (642)
Cancer (4816)
Cardiovascular disease (402)
Career advice (1734)
Career pathing (36)
CAR-T (282)
CDC (47)
Celiac Disease (2)
Cell therapy (746)
Cervical cancer (36)
Clinical research (69874)
Collaboration (1710)
Company closure (4)
Compensation (1156)
Complete response letters (56)
COVID-19 (2838)
CRISPR (87)
C-suite (847)
Cystic fibrosis (143)
Data (6221)
Decentralized trials (2)
Denatured (28)
Depression (134)
Diabetes (502)
Diagnostics (6739)
Digital health (48)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (251)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (90249)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (118174)
Executive appointments (978)
FDA (19635)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1477)
Gene editing (194)
Generative AI (43)
Gene therapy (597)
GLP-1 (979)
Government (4774)
Grass and pollen (6)
Guidances (383)
Healthcare (19091)
HIV (58)
Huntington's disease (44)
IgA nephropathy (82)
Immunology and inflammation (252)
Immuno-oncology (58)
Indications (109)
Infectious disease (3110)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (249)
Interviews (322)
IPO (16675)
IRA (50)
Job creations (3678)
Job search strategy (1448)
JPM (59)
Kidney cancer (16)
Labor market (86)
Layoffs (551)
Leadership (32)
Legal (8011)
Liver cancer (91)
Longevity (14)
Lung cancer (650)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (794)
MASH (164)
Medical device (13856)
Medtech (13910)
Mergers & acquisitions (20087)
Metabolic disorders (1275)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (318)
Neuropsychiatric disorders (89)
Neuroscience (2912)
Neurotech (1)
NextGen: Class of 2026 (6581)
Non-profit (4586)
Now hiring (67)
Obesity (598)
Opinion (268)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (227)
Parkinson's disease (281)
Partnered (33)
Patents (495)
Patient recruitment (488)
Peanut (57)
People (59321)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21791)
Phase 2 (30731)
Phase 3 (22932)
Pipeline (5267)
Policy (286)
Postmarket research (2577)
Preclinical (9256)
Press Release (65)
Prostate cancer (238)
Psychedelics (49)
Radiopharmaceuticals (282)
Rare diseases (836)
Real estate (6003)
Recruiting (70)
Regulatory (24708)
Reports (52)
Research institute (2415)
Resumes & cover letters (355)
Rett syndrome (27)
RNA editing (17)
RSV (78)
Schizophrenia (150)
Series A (241)
Series B (190)
Service/supplier (12)
Sickle cell disease (96)
Special edition (21)
Spinal muscular atrophy (159)
Sponsored (43)
Startups (3662)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (56)
Vaccines (1043)
Venture capital (92)
Weight loss (386)
Women's health (89)
Worklife (18)
Date
Today (151)
Last 7 days (574)
Last 30 days (2104)
Last 365 days (30103)
2026 (3346)
2025 (30334)
2024 (35399)
2023 (40254)
2022 (51405)
2021 (56008)
2020 (54591)
2019 (46915)
2018 (35359)
2017 (32314)
2016 (31768)
2015 (37803)
2014 (31593)
2013 (26642)
2012 (28859)
2011 (29529)
2010 (27636)
Location
Africa (766)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39837)
Australia (6489)
California (11281)
Canada (3281)
China (1103)
Colorado (478)
Connecticut (475)
Delaware (335)
Europe (85615)
Florida (1687)
Georgia (355)
Hawaii (3)
Idaho (61)
Illinois (860)
India (66)
Indiana (520)
Iowa (22)
Japan (429)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1390)
Massachusetts (8096)
Michigan (323)
Minnesota (627)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (29)
Nevada (122)
New Hampshire (78)
New Jersey (3002)
New Mexico (29)
New York (2974)
North Carolina (1473)
North Dakota (8)
Northern California (5507)
Ohio (333)
Oklahoma (21)
Oregon (41)
Pennsylvania (2276)
Puerto Rico (24)
Rhode Island (47)
South America (1129)
South Carolina (66)
South Dakota (1)
Southern California (4388)
Tennessee (174)
Texas (1743)
United States (40048)
Utah (337)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (920)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
727,285 Results for "emergent biosolutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
·
1 min read
Legal
Former Emergent CEO Hit With Insider Trading Lawsuit
Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with information related to the company’s manufacturing operations that had yet to be made public.
January 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
January 8, 2026
·
3 min read
Press Releases
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 7, 2026
·
1 min read
Press Releases
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
January 12, 2026
·
2 min read
Press Releases
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
October 30, 2025
·
38 min read
Press Releases
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
November 13, 2025
·
1 min read
Press Releases
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
December 15, 2025
·
4 min read
Press Releases
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
January 9, 2026
·
3 min read
Press Releases
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
November 19, 2025
·
10 min read
1 of 72,729
Next
